Introduction
Hypertrophic cardiomyopathy (HCM) presents a complex challenge for patients and healthcare providers alike, often characterized by the abnormal thickening of the heart muscle. Early diagnosis is crucial for effective management, and individuals facing this condition must navigate a landscape filled with various treatment options. This article explores ten essential strategies for managing HCM, from innovative medications to lifestyle changes and surgical interventions.
As the medical community continues to uncover advancements in care, we must ask ourselves: what are the best paths to ensure optimal health and quality of life for those affected by this often-overlooked heart condition? Together, we can find the answers and support one another on this journey.
Amavita Heart and Vascular Health: Leading Care for Hypertrophic Cardiomyopathy
At Amavita Heart and Vascular Health, we understand how concerning it can be to face a condition like hypertrophic cardiomyopathy, which involves an abnormal thickening of the heart muscle. Under the compassionate guidance of Dr. Martinez-Clark, who has dedicated his career to enhancing heart medicine, our team is here to support you. We utilize advanced treatment protocols and technologies designed to achieve the best outcomes for each individual.
Dr. Martinez-Clark is known for his empathetic approach, fostering genuine relationships with those he treats. He provides honest and clear information about their conditions, ensuring patients feel informed and valued. His leadership in over 25 clinical trials, including the innovative Trans-Caval method, means that our patients often have access to the latest treatments even before they become widely available elsewhere.
This commitment to patient care and cutting-edge techniques makes Amavita a leader in navigating hypertrophic cardiomyopathy. We are here to help you every step of the way, ensuring you receive the support and understanding you deserve.
Early Diagnosis: Key to Effective Hypertrophic Cardiomyopathy Treatment
Recognizing the symptoms of hypertrophic cardiomyopathy (HCM) early is crucial for effective management. Many individuals may experience:
- Shortness of breath
- Chest pain
- Palpitations
Research indicates that those diagnosed early can significantly improve their outcomes with appropriate treatment options, as associated with this condition. Regular check-ups and screenings are essential, particularly for those with a family history of heart disease, to facilitate early intervention.
At Amavita Heart and Vascular Health®, we understand the importance of thorough evaluations. Our approach includes medical assessments and lifestyle modifications that support patient health and well-being. Did you know that approximately 85% of individuals with HCM may remain undiagnosed? This statistic highlights the need for awareness and proactive health monitoring.
By prioritizing early diagnosis and taking advantage of our comprehensive services, you can access a broader range of therapies. This proactive approach not only enhances your options for treatment but also improves your overall quality of life. Remember, we are here to support you every step of the way, ensuring you feel valued and cared for in your health journey.
Medications for Hypertrophic Cardiomyopathy: Essential Treatments and Their Benefits
Managing hypertrophic cardiomyopathy treatment can be challenging, but medications such as beta-blockers and calcium channel blockers are here to help. These medications effectively alleviate symptoms like chest pain and shortness of breath, providing relief for those affected. At Amavita Heart and Vascular Health, our specialists recognize the importance of treatment options and overall mortality for individuals with heart failure with preserved ejection fraction (HFpEF), a condition often associated with HCM. In fact, studies reveal that over 75% of individuals with HFpEF are treated with beta-blockers, highlighting their essential role despite ongoing discussions about their efficacy in certain groups.
They assist in lowering heart rate and improving blood flow, making them particularly beneficial for those who may not tolerate beta-blockers well. However, it’s important to be aware that while CCBs can lower the likelihood of adverse cardiovascular events, they may not be suitable for all patients. This makes CCBs a valuable option for individuals seeking alternative treatments.
At Amavita, we pride ourselves on working closely with individuals to create personalized treatment plans that align with their unique health profiles, especially in the context of hypertrophic cardiomyopathy treatment. Our patient-centered approach not only enhances the effectiveness of hypertrophic cardiomyopathy treatment but also fosters a supportive environment for navigating the complexities of this condition. Furthermore, we utilize advanced therapies and minimally invasive procedures, ensuring that each individual receives comprehensive care tailored to their specific needs. Remember, you are not alone on this journey; we are here to support you every step of the way.
Surgical Options: When to Consider Procedures for Hypertrophic Cardiomyopathy
When medications do not sufficiently control the symptoms of hypertrophic cardiomyopathy (HCM), it can be concerning for patients and their loved ones. Surgical options are valuable options to consider for treatment. These procedures are part of the management plan, aiming to reduce the thickness of the heart muscle, enhance blood flow, and alleviate distressing symptoms. Notably, septal myectomy has shown remarkable outcomes, with survival rates at 1, 5, and 10 years being 98%, 96%, and 83%, respectively, which are comparable to those of the general population. This surgical approach is especially beneficial for individuals experiencing severe drug-refractory symptoms, as it significantly improves quality of life and reduces the risk of sudden cardiac death.
In contrast, while alcohol septal ablation is less invasive, it has been associated with higher long-term all-cause mortality compared to myectomy, highlighting the importance of careful patient selection. Patients who undergo surgical myectomy often experience symptom relief and hemodynamic improvement following the operation. The surgical team is dedicated to these patients, ensuring that each patient receives personalized care and attention to their unique circumstances.
By utilizing the latest techniques and insights from leading experts, we are committed to delivering optimal outcomes through surgical interventions for individuals facing hypertrophic cardiomyopathy challenges. Additionally, through our CardioElite™ program, we enhance cardiac care by integrating advanced diagnostic data and providing 24/7 cardiology consultation. This integration not only facilitates proactive management but also addresses the high cardiovascular readmission rates at skilled nursing facilities, ultimately transforming the approach to cardiac care for our patients. We understand that navigating these health challenges can be daunting, but rest assured, we are here to support you every step of the way.
Lifestyle Changes: Enhancing Hypertrophic Cardiomyopathy Management
Embracing a healthy lifestyle is essential for effective management of hypertrophic cardiomyopathy. Have you considered how lifestyle changes can make a difference? Engaging in physical activities like walking, yoga, and tai chi can significantly improve health and alleviate symptoms. Research shows that such activities help lower heart rate and blood pressure, which is particularly beneficial for individuals with HCM. By focusing on regular exercise, you can enhance your cardiovascular function without putting undue strain on your heart.
A balanced diet is another cornerstone in managing hypertrophic cardiomyopathy. It’s important to prioritize a nutritious diet while minimizing saturated fats, sodium, and added sugars. Additionally, limiting alcohol consumption and avoiding smoking are crucial steps, as these factors can worsen HCM symptoms. This dietary approach not only promotes overall cardiovascular health but also aids in weight management, which is vital, as being overweight can exacerbate the need for medical intervention.
Have you tried relaxation techniques such as deep breathing, meditation, or ensuring you get enough sleep? These practices can help reduce stress, which is known to elevate blood pressure and worsen heart conditions. According to NYU Langone heart specialists, “Exercise is essential for health and wellbeing, and we encourage people with HCM to exercise.”
Amavita Heart and Vascular Health offers resources and support in adopting these lifestyle changes, fostering a proactive approach to managing hypertrophic cardiomyopathy. By integrating these strategies, you can enhance your quality of life and better manage your condition. Remember, you are not alone on this journey; support is available to help you every step of the way.
Regular Monitoring: Ensuring Ongoing Care for Hypertrophic Cardiomyopathy Patients
Routine follow-up visits are vital for individuals undergoing treatment for hypertrophic cardiomyopathy. These visits not only allow for assessment of symptoms and therapeutic effectiveness but also empower healthcare providers to tailor treatment plans to meet individual needs. Have you ever wondered how consistent care can impact your health? Research shows that regular follow-up can lead to improved health outcomes, with studies indicating that individuals who engage in monitoring experience fewer complications and enjoy a better quality of life. It’s heartening to note that mortality rates for those with HCM have improved to around 0.5%, underscoring the importance of ongoing care.
The Optimal Program, available for $416/month, offers comprehensive biomarker panels and assessments, including a cardiac calcium score. This ensures that you receive thorough evaluations and recommendations tailored to your unique situation. Furthermore, the latest 2024 guidelines advocate for routine assessments and recommend monitoring for all asymptomatic HCM individuals. This aligns with our commitment to providing optimal care strategies that support your health.
Experts emphasize the significance of maintaining a strong patient-provider relationship. Such connections not only foster trust but also encourage you to actively participate in your care. This active engagement can lead to better health outcomes and improved overall outcomes for those living with HCM. Remember, you are not alone in this journey; support is always available to help you thrive.
Patient Education and Support: Resources for Living with Hypertrophic Cardiomyopathy
At Amavita, we are deeply committed to enhancing the lives of individuals living with hypertrophic cardiomyopathy (HCM) by offering a wide array of resources designed to empower and support. Did you know that HCM affects approximately one in every 500 people? This statistic underscores the vital need for education and support for many individuals and their families.
Our offerings include:
- Comprehensive informational brochures
- Engaging workshops
- Access to support groups where individuals can connect, share their experiences, and exchange valuable coping strategies
By equipping individuals with knowledge, we play a crucial role in their journey, helping them navigate challenges with confidence and resilience.
Research shows that when individuals are informed, they are better equipped to take an active role in their care, leading to improved outcomes and a stronger sense of empowerment. It’s also important to note that a child of an affected parent has a 50 percent chance of inheriting the genetics that can lead to HCM. This reality highlights the necessity of family education and awareness, ensuring that everyone is aware and prepared.
Support networks are essential in this journey, offering a nurturing environment for emotional support and shared learning. These connections can significantly influence the management of HCM, fostering a sense of community that is so important. The Hypertrophic Cardiomyopathy Association (HCMA) stands out as a valuable resource, advocating for education and creating a supportive network that encourages understanding and compassion.
By guiding individuals through their diagnosis and helping them thrive on their journey toward improved heart health, Amavita emphasizes the importance of education in managing treatment. We invite you to reach out and explore the resources available to you—together, we can make a difference in your health and well-being.
Complications of Hypertrophic Cardiomyopathy: Understanding and Mitigating Risks
Hypertrophic cardiomyopathy (HCM) poses significant risks, including stroke and heart failure, which can deeply impact individual health. It’s essential to recognize warning signs; symptoms like sudden shortness of breath, fainting, or palpitations should prompt immediate medical attention. Research indicates that about 25% of individuals with HCM experience arrhythmias, with atrial fibrillation being the most common. This underscores the importance for individuals to be vigilant about their symptoms and to engage in discussions regarding any concerns.
At Amavita, we are committed to providing care and support for conditions such as chest pain and heart rhythm disorders. Our specialists utilize advanced diagnostic imaging to identify potential blockages and abnormalities, ensuring that individuals receive timely and effective care. For those experiencing chest discomfort, our minimally invasive procedures, including cardiac catheterization and stent placement, can restore blood flow, allowing most individuals to return home the same day with relief from their symptoms.
Furthermore, Amavita offers comprehensive arrhythmia management, employing continuous monitoring technology to accurately identify the specific type of arrhythmia and provide treatment. This outpatient approach minimizes disruption to individuals’ lives while achieving excellent results.
Patient education plays a vital role in managing the risks associated with HCM and its complications. By fostering awareness of potential challenges, individuals can more effectively navigate their care journey. Recent research emphasizes the significance of early intervention and monitoring in HCM management, as this can lead to improved outcomes. We encourage patients to share and discuss any personal symptoms with their healthcare providers, as this information is crucial for developing effective management plans. A collaborative approach among healthcare professionals is essential to ensure comprehensive care and optimal outcomes in HCM.
Innovative Research: Advancements in Hypertrophic Cardiomyopathy Treatment
At the forefront of innovative research, our organization is dedicated to enhancing treatment options for those affected by HCM. We understand that navigating health concerns can be daunting, which is why we engage in initiatives that provide individuals access to therapies not yet widely available. This commitment reflects our deep-seated dedication to improving patient outcomes.
Recent studies have shown promising results for new therapies, such as mavacamten and aficamten, which represent advancements in treatment by targeting the underlying causes of obstructive HCM. Mavacamten stands out as the first FDA-approved drug specifically for hypertrophic cardiomyopathy, demonstrating efficacy and decreasing the need for invasive procedures. We are excited to share that ongoing trials at esteemed institutions like Oregon Health & Science University are exploring aficamten’s efficacy. These trials reveal its potential to enhance quality of life, ultimately improving daily functioning for patients.
Our dedication to research not only underscores our mission to deliver exceptional care but also positions us as a leader in the evolving landscape of treatment options. Furthermore, we are proud to implement AI-powered point-of-care ultrasound technology in underserved communities. This initiative enables faster and more efficient diagnoses for conditions like hypertrophic cardiomyopathy and other valvular diseases, ensuring that everyone has access to necessary care.
We invite you to reach out for support and to learn more about how these advancements can positively impact your health journey. Remember, you are not alone—we are here to help you every step of the way.
Multidisciplinary Approach: Collaborative Care for Hypertrophic Cardiomyopathy
Effective management of hypertrophic cardiomyopathy requires a compassionate and collaborative team of healthcare professionals, including:
- Cardiologists
- Surgeons
- Nutritionists
- Physical therapists
At Amavita Heart and Vascular Health, we embrace this approach, ensuring that every aspect of your health is thoughtfully addressed. This teamwork is especially beneficial for older individuals who often face various health challenges that require comprehensive care.
In addition to this, by integrating specialties such as cardiology and genetics counseling, Amavita enhances treatment efficacy and improves outcomes for individuals like you. We foster a supportive environment. Success stories from elderly patients truly highlight the positive impact of this collaborative model, showcasing how teamwork, particularly among specialists, lead to better management of HCM and an overall improved quality of life. Remember, you are not alone on this journey; we are here to support you every step of the way.
Conclusion
Managing hypertrophic cardiomyopathy (HCM) can feel overwhelming, but it doesn’t have to be a solitary journey. It’s crucial to recognize symptoms early and engage in proactive management strategies that can significantly improve health outcomes. By working closely with dedicated healthcare professionals and exploring tailored treatment options, individuals with HCM can navigate their condition with greater confidence and a better quality of life.
Early detection is essential. Medications like beta-blockers and calcium channel blockers play a vital role in managing symptoms, and sometimes surgical interventions may be necessary if symptoms persist despite pharmacological management. Embracing lifestyle changes, committing to regular monitoring, and prioritizing patient education are all key elements in comprehensive HCM care. This collaborative approach, involving a multidisciplinary team of specialists, reinforces the importance of support and shared expertise.
In addition to this, ongoing research and innovative therapies are paving the way for new treatment avenues. This ensures that patients have access to the latest advancements in care, which is a source of hope and empowerment.
Ultimately, living with hypertrophic cardiomyopathy can be a journey filled with support and resources. By taking a proactive stance, individuals can empower themselves with knowledge, seek out support, and connect with healthcare providers to create personalized care plans. The resources available, from educational materials to support groups, are invaluable in fostering a sense of community and resilience. Taking these steps not only enhances personal well-being but also contributes to a broader understanding and management of this condition. With the right support and resources, individuals can thrive, even in the face of challenges posed by hypertrophic cardiomyopathy.
Frequently Asked Questions
What is hypertrophic cardiomyopathy (HCM)?
Hypertrophic cardiomyopathy is a condition characterized by the abnormal thickening of the heart muscle, which can lead to various symptoms and complications.
How does Amavita Heart and Vascular Health support patients with HCM?
Amavita Heart and Vascular Health offers compassionate care under the guidance of Dr. Pedro Martinez-Clark, utilizing advanced diagnostic tools and customized care strategies to achieve optimal outcomes for each patient.
What are the early symptoms of hypertrophic cardiomyopathy?
Early symptoms of HCM can include shortness of breath, chest pain, and palpitations.
Why is early diagnosis important for HCM?
Early diagnosis is crucial as it significantly improves treatment outcomes and helps mitigate risks associated with HCM. Regular check-ups and screenings are essential for early detection, especially for individuals with a family history of heart disease.
What medications are commonly used to treat hypertrophic cardiomyopathy?
Common medications for HCM treatment include beta-blockers and calcium channel blockers (CCBs). Beta-blockers help alleviate symptoms and lower the risk of hospitalization, while CCBs improve blood flow and heart rate.
What role do beta-blockers play in HCM treatment?
Beta-blockers are essential in managing symptoms like chest pain and shortness of breath, and they significantly lower the risk of hospitalization and mortality for individuals with heart failure with preserved ejection fraction (HFpEF), often associated with HCM.
How do calcium channel blockers (CCBs) assist in HCM treatment?
CCBs lower heart rate and improve blood flow, making them beneficial for patients who may not tolerate beta-blockers. However, they may also carry heightened risks for some individuals.
What approach does Amavita take in medication management for HCM?
Amavita focuses on creating personalized medication plans that align with each patient’s unique health profile, ensuring comprehensive care tailored to individual needs.
How does Amavita ensure comprehensive care for HCM patients?
Amavita employs advanced diagnostic imaging and minimally invasive procedures, alongside a patient-centered approach, to provide effective and supportive care for those navigating the complexities of HCM.
List of Sources
- Amavita Heart and Vascular Health: Leading Care for Hypertrophic Cardiomyopathy
- healio.com (https://healio.com/news/cardiology/20231013/one-giant-leap-for-hcm-gene-therapy-may-reverse-hypertrophic-cardiomyopathy)
- news.umiamihealth.org (https://news.umiamihealth.org/en/breakthroughs-in-the-treatment-of-hypertrophic-cardiomyopathy)
- lahey.org (https://lahey.org/news-stories/all-news-stories/news/2024/05/new-treatment-in-pipeline-for-patients-with-hypertrophic-cardiomyopathy)
- Cleveland Clinic Performs World’s First In-Human Gene Therapy for Hypertrophic Cardiomyopathy (https://newsroom.clevelandclinic.org/2023/10/05/cleveland-clinic-performs-worlds-first-in-human-gene-therapy-for-hypertrophic-cardiomyopathy)
- mayoclinic.org (https://mayoclinic.org/medical-professionals/cardiovascular-diseases/news/new-hypertrophic-cardiomyopathy-clinical-guideline-recommends-novel-drug-therapy-and-regular-exercise/mac-20569318)
- Early Diagnosis: Key to Effective Hypertrophic Cardiomyopathy Treatment
- parade.com (https://parade.com/1187612/michelle-parkerton/quotes-about-heart-disease)
- mdpi.com (https://mdpi.com/2227-9059/13/9/2138)
- reachmd.com (https://reachmd.com/news/trim63-and-early-diagnosis-new-perspectives-on-hypertrophic-cardiomyopathy/2474300)
- Prevalence, incidence and mortality of hypertrophic cardiomyopathy based on a population cohort of 21.9 million in China – Scientific Reports (https://nature.com/articles/s41598-022-20042-9)
- news.bms.com (https://news.bms.com/news/details/2021/Bristol-Myers-Squibb-Launches-Could-It-Be-HCM-Campaign-to-Increase-Awareness-of-Hypertrophic-Cardiomyopathy-HCM-the-Most-Common-Inherited-Heart-Disease/default.aspx)
- Medications for Hypertrophic Cardiomyopathy: Essential Treatments and Their Benefits
- healio.com (https://healio.com/news/cardiology/20230629/patients-with-hfpef-would-benefit-more-from-betablockers-vs-calcium-channel-blockers)
- abcnews.go.com (https://abcnews.go.com/Health/doctors-rethink-decades-routine-beta-blocker-patients-after/story?id=125112970)
- Calcium channel blockers (https://mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/calcium-channel-blockers/art-20047605)
- newsroom.wakehealth.edu (https://newsroom.wakehealth.edu/news-releases/2000/12/calcium-channel-blockers-not-as-effective-as-other-drugs)
- pmc.ncbi.nlm.nih.gov (https://pmc.ncbi.nlm.nih.gov/articles/PMC11275245)
- Surgical Options: When to Consider Procedures for Hypertrophic Cardiomyopathy
- sciencedirect.com (https://sciencedirect.com/science/article/pii/S0735109705010466)
- annalscts.com (https://annalscts.com/article/view/15786/15854)
- jacc.org (https://jacc.org/doi/10.1016/j.jacc.2022.02.032)
- pmc.ncbi.nlm.nih.gov (https://pmc.ncbi.nlm.nih.gov/articles/PMC11090985)
- pmc.ncbi.nlm.nih.gov (https://pmc.ncbi.nlm.nih.gov/articles/PMC7947546)
- Lifestyle Changes: Enhancing Hypertrophic Cardiomyopathy Management
- nyulangone.org (https://nyulangone.org/conditions/hypertrophic-cardiomyopathy/treatments/lifestyle-changes-for-hypertrophic-cardiomyopathy)
- mayoclinic.org (https://mayoclinic.org/medical-professionals/cardiovascular-diseases/news/new-hypertrophic-cardiomyopathy-clinical-guideline-recommends-novel-drug-therapy-and-regular-exercise/mac-20569318)
- newsroom.heart.org (https://newsroom.heart.org/news/exercise-new-drug-class-recommended-for-management-of-hypertrophic-cardiomyopathy)
- mcpress.mayoclinic.org (https://mcpress.mayoclinic.org/healthy-heart/lifestyle-steps-when-managing-hypertrophic-cardiomyopathy)
- Regular Monitoring: Ensuring Ongoing Care for Hypertrophic Cardiomyopathy Patients
- mayoclinic.org (https://mayoclinic.org/medical-professionals/cardiovascular-diseases/news/new-hypertrophic-cardiomyopathy-clinical-guideline-recommends-novel-drug-therapy-and-regular-exercise/mac-20569318)
- 10 Patient Experience Quotes for Inspiration (https://carecloud.com/continuum/patient-experience-quotes-for-inspiration)
- 10 Inspiring Patient Experience Quotes | Relias (https://relias.com/blog/patient-experience-quotes)
- Hypertrophic Cardiomyopathy – StatPearls – NCBI Bookshelf (https://ncbi.nlm.nih.gov/books/NBK430788)
- theeducatedpatient.com (https://theeducatedpatient.com/view/christopher-kramer-m-d-the-importance-of-comprehensive-care-in-hcm)
- Patient Education and Support: Resources for Living with Hypertrophic Cardiomyopathy
- 4hcm.org (https://4hcm.org)
- pennstatehealthnews.org (https://pennstatehealthnews.org/2023/08/the-medical-minute-understanding-hypertrophic-cardiomyopathy)
- acc.org (https://acc.org/Latest-in-Cardiology/Articles/2025/08/19/14/10/ACC-Launches-HCM-Digital-Registry)
- connect.mayoclinic.org (https://connect.mayoclinic.org/group/hypertrophic-cardiomyopathy-hcm)
- bms.com (https://bms.com/life-and-science/news-and-perspectives/amplifying-patient-voices-to-enhance-hcm-care.html)
- Complications of Hypertrophic Cardiomyopathy: Understanding and Mitigating Risks
- newsroom.heart.org (https://newsroom.heart.org/news/new-effort-to-improve-care-for-hidden-heart-disease)
- mayoclinic.org (https://mayoclinic.org/medical-professionals/cardiovascular-diseases/news/new-hypertrophic-cardiomyopathy-clinical-guideline-recommends-novel-drug-therapy-and-regular-exercise/mac-20569318)
- TIME.com: Understanding 4 of the Most Common Complications of Hypertrophic Cardiomyopathy (https://cedars-sinai.org/newsroom/timecom-understanding-4-of-the-most-common-complications-of-hypertrophic-cardiomyopathy)
- Hypertrophic Cardiomyopathy – StatPearls – NCBI Bookshelf (https://ncbi.nlm.nih.gov/books/NBK430788)
- pennstatehealthnews.org (https://pennstatehealthnews.org/2023/08/the-medical-minute-understanding-hypertrophic-cardiomyopathy)
- Innovative Research: Advancements in Hypertrophic Cardiomyopathy Treatment
- news.ohsu.edu (https://news.ohsu.edu/2024/05/13/new-drug-makes-exercise-everyday-tasks-easier-for-people-with-common-heart-condition)
- newsroom.clevelandclinic.org (https://newsroom.clevelandclinic.org/2025/08/30/cleveland-clinic-led-trials-shows-drug-doesnt-significantly-improve-outcomes-in-patients-with-non-obstructive-hypertrophic-cardiomyopathy)
- acc.org (https://acc.org/Latest-in-Cardiology/Clinical-Trials/2022/04/01/02/42/VALOR-HCM)
- New Treatment Approaches for Hypertrophic Cardiomyopathy (https://nyulangone.org/news/new-treatment-approaches-hypertrophic-cardiomyopathy)
- hfsa.org (https://hfsa.org/clinical-trial-now-enrolling-patients-hypertrophic-cardiomyopathy-hcm-without-obstruction)
- Multidisciplinary Approach: Collaborative Care for Hypertrophic Cardiomyopathy
- hopkinsmedicine.org (https://hopkinsmedicine.org/news/articles/2023/01/a-multidisciplinary-approach-to-hypertrophic-cardiomyopathy-the-right-treatment-for-each-patient)
- newsroom.heart.org (https://newsroom.heart.org/news/15-regions-chosen-for-groundbreaking-effort-to-reduce-cardiovascular-disease)
- lahey.org (https://lahey.org/news-stories/all-news-stories/news/2022/04/lahey-hospital-medical-center-opens-new-hypertrophic-cardiomyopathy-center)
- valleyhealth.com (https://valleyhealth.com/newsroom/valley-health-system-opens-knispel-center-comprehensive-cardiomyopathy-care)
Leave a Reply